LEVALBUTEROL HYDROCHLORIDE

LEVALBUTEROL HYDROCHLORIDE was reported 3637 times

LEVALBUTEROL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED FACTOR V DEFICIENCY 21 0.1909
1 COAGULATION FACTOR DEFICIENCY 30 0.1863
2 COAGULATION FACTOR V LEVEL ABNORMAL 21 0.1707
3 BRAIN NATRIURETIC PEPTIDE DECREASED 4 0.0476
4 FACTOR V LEIDEN MUTATION 17 0.0428
5 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 32 0.0345
6 BRONCHOMALACIA 3 0.0227
7 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 15 0.0168
8 JEJUNOSTOMY 3 0.0165
9 CREATININE RENAL CLEARANCE INCREASED 10 0.0134
10 MULTIPLE DRUG THERAPY 9 0.0119
11 TOXIC OPTIC NEUROPATHY 5 0.0115
12 SEDATION COMPLICATION 29 0.0114
13 TRACHEITIS 8 0.0105
14 BRONCHOSPASM PARADOXICAL 3 0.0100
15 DEATH OF RELATIVE 4 0.0099
16 INFECTIVE EXACERBATION OF BRONCHIECTASIS 3 0.0098
17 ASPERGILLUS TEST POSITIVE 3 0.0097
18 DEFECT CONDUCTION INTRAVENTRICULAR 3 0.0093
19 GIARDIASIS 3 0.0088
20 TRACHEAL HAEMORRHAGE 3 0.0085
21 INCREASED VISCOSITY OF BRONCHIAL SECRETION 5 0.0078
22 LOWER RESPIRATORY TRACT INFECTION FUNGAL 3 0.0077
23 TRACHEOMALACIA 3 0.0076
24 CREATININE RENAL CLEARANCE DECREASED 29 0.0072
25 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 37 0.0068
26 STATUS ASTHMATICUS 3 0.0064
27 CYSTIC FIBROSIS 35 0.0063
28 MULTIPLE ALLERGIES 48 0.0061
29 INFUSION SITE BRUISING 13 0.0060
30 INFUSION SITE URTICARIA 4 0.0060
31 INFUSION SITE DISCOLOURATION 5 0.0057
32 ESSENTIAL HYPERTENSION 10 0.0055
33 OEDEMATOUS PANCREATITIS 3 0.0053
34 URINARY TRACT INFECTION PSEUDOMONAL 3 0.0050
35 CHRONIC RESPIRATORY FAILURE 6 0.0050
36 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
37 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
38 ENTEROVIRUS INFECTION 4 0.0046
39 CYSTOCELE 4 0.0046
40 HYPERMAGNESAEMIA 3 0.0046
41 KIDNEY ENLARGEMENT 5 0.0046
42 INFUSION SITE HAEMORRHAGE 15 0.0046
43 SPUTUM ABNORMAL 3 0.0045
44 INFUSION SITE RASH 6 0.0044
45 RHINOVIRUS INFECTION 17 0.0044
46 TRACHEOSTOMY 6 0.0042
47 VENTRICULAR HYPOKINESIA 13 0.0040
48 SPUTUM RETENTION 4 0.0040
49 INFUSION SITE DISCHARGE 7 0.0040
50 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 3 0.0039
51 DIAPHRAGMATIC DISORDER 3 0.0039
52 PNEUMONIA PSEUDOMONAL 6 0.0039
53 CROUP INFECTIOUS 3 0.0038
54 INFUSION SITE PRURITUS 12 0.0038
55 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
56 RENAL FUNCTION TEST ABNORMAL 17 0.0037
57 DYSCHROMATOPSIA 3 0.0036
58 IMPAIRED QUALITY OF LIFE 52 0.0036
59 MAST CELL ACTIVATION SYNDROME 5 0.0036
60 VOCAL CORD DISORDER 7 0.0035
61 NOROVIRUS INFECTION 5 0.0035
62 PULMONARY CAVITATION 3 0.0034
63 RESPIRATORY TRACT INFECTION VIRAL 8 0.0034
64 ANAEMIA OF CHRONIC DISEASE 3 0.0033
65 BRONCHITIS CHRONIC 8 0.0033
66 PSEUDOMONAS INFECTION 27 0.0031
67 PROSTATE INFECTION 3 0.0031
68 PNEUMONIA STAPHYLOCOCCAL 6 0.0030
69 INFUSION SITE SWELLING 19 0.0030
70 MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0030
71 BRONCHIECTASIS 20 0.0030
72 SEASONAL ALLERGY 42 0.0030
73 NASAL INFLAMMATION 3 0.0028
74 NEPHROGENIC ANAEMIA 13 0.0028
75 INFUSION SITE MASS 3 0.0028
76 CONJUNCTIVITIS ALLERGIC 4 0.0027
77 BLOOD CALCIUM DECREASED 30 0.0027
78 PNEUMONIA INFLUENZAL 3 0.0025
79 PULMONARY FUNCTION TEST DECREASED 11 0.0025
80 INFUSION SITE WARMTH 3 0.0024
81 POST-ACUTE COVID-19 SYNDROME 3 0.0024
82 PULMONARY PAIN 7 0.0024
83 HYPERPARATHYROIDISM SECONDARY 6 0.0024
84 VEIN RUPTURE 4 0.0024
85 PARANASAL SINUS DISCOMFORT 9 0.0024
86 BRONCHIAL SECRETION RETENTION 3 0.0024
87 INFUSION SITE IRRITATION 3 0.0023
88 CATHETER SITE ERYTHEMA 5 0.0023
89 ASTHMA 264 0.0023
90 HYPERPHOSPHATAEMIA 5 0.0023
91 CONGENITAL ANOMALY 18 0.0023
92 CENTRAL VENOUS CATHETERISATION 7 0.0023
93 ACUTE SINUSITIS 4 0.0023
94 SPUTUM INCREASED 5 0.0023
95 PNEUMONIA FUNGAL 9 0.0023
96 CARBON DIOXIDE INCREASED 3 0.0022
97 PNEUMONIA VIRAL 7 0.0022
98 TORSADE DE POINTES 17 0.0022
99 DISCHARGE 3 0.0022
100 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 111 0.0021
101 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
102 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
103 ADENOVIRUS INFECTION 6 0.0021
104 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
105 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
106 PRECANCEROUS SKIN LESION 3 0.0020
107 RHINITIS ALLERGIC 9 0.0020
108 ORTHOSTATIC HYPOTENSION 35 0.0020
109 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
110 RUBBER SENSITIVITY 3 0.0020
111 INJECTION SITE PARAESTHESIA 3 0.0020
112 NEURITIS 3 0.0019
113 INFUSION SITE PAIN 25 0.0019
114 GASTROSTOMY 3 0.0019
115 CATHETER SITE PAIN 5 0.0019
116 GASTROINTESTINAL STOMA COMPLICATION 3 0.0019
117 PHARYNGEAL PARAESTHESIA 3 0.0019
118 AORTIC VALVE DISEASE 3 0.0019
119 PULMONARY ARTERIAL PRESSURE INCREASED 3 0.0018
120 PARANASAL SINUS HYPERSECRETION 7 0.0018
121 BREATH SOUNDS ABNORMAL 9 0.0018
122 RESPIRATORY TRACT INFECTION 47 0.0018
123 CATHETERISATION CARDIAC 8 0.0018
124 ANXIETY DISORDER 6 0.0018
125 INFUSION SITE ERYTHEMA 15 0.0018
126 ACUTE RESPIRATORY FAILURE 34 0.0018
127 OXYGEN SATURATION ABNORMAL 5 0.0018
128 PERIARTHRITIS 4 0.0018
129 VITAMIN D DEFICIENCY 17 0.0017
130 MYCOBACTERIAL INFECTION 3 0.0017
131 SPLENIC INFARCTION 3 0.0017
132 MITRAL VALVE DISEASE 3 0.0017
133 RADIUS FRACTURE 4 0.0017
134 BLOOD IMMUNOGLOBULIN E INCREASED 4 0.0017
135 OTOTOXICITY 3 0.0016
136 EYELIDS PRURITUS 5 0.0016
137 SPUTUM DISCOLOURED 15 0.0016
138 SECRETION DISCHARGE 19 0.0015
139 PRODUCTIVE COUGH 72 0.0015
140 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
141 CHEST INJURY 3 0.0014
142 LUNG CONSOLIDATION 4 0.0014
143 PNEUMONIA BACTERIAL 13 0.0014
144 LUNG TRANSPLANT 5 0.0014
145 FORCED EXPIRATORY VOLUME DECREASED 4 0.0014
146 RESPIRATORY SYMPTOM 4 0.0014
147 JAW FRACTURE 3 0.0014
148 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
149 CANDIDA INFECTION 23 0.0014
150 VENTRICULAR EXTRASYSTOLES 14 0.0013
151 INFUSION SITE REACTION 4 0.0013
152 CHRONIC SINUSITIS 5 0.0013
153 HYPERCAPNIA 4 0.0013
154 BLOOD LOSS ANAEMIA 3 0.0013
155 RESPIRATORY TRACT CONGESTION 21 0.0013
156 OXYGEN SATURATION DECREASED 74 0.0013
157 EYE INJURY 4 0.0013
158 INFUSION SITE INFECTION 3 0.0013
159 FLANK PAIN 12 0.0013
160 MYOPIA 3 0.0013
161 SEDATION 33 0.0013
162 SINUS CONGESTION 17 0.0013
163 ORTHOPNOEA 4 0.0013
164 OXYGEN CONSUMPTION INCREASED 3 0.0013
165 OBSTRUCTION 5 0.0013
166 ATELECTASIS 12 0.0012
167 UPPER RESPIRATORY TRACT INFECTION 56 0.0012
168 OTITIS MEDIA 4 0.0012
169 DEVICE INFUSION ISSUE 3 0.0012
170 SUFFOCATION FEELING 3 0.0012
171 EAR INFECTION 32 0.0012
172 BRONCHITIS 89 0.0012
173 GASTROINTESTINAL TUBE INSERTION 3 0.0012
174 INCREASED BRONCHIAL SECRETION 3 0.0012
175 HEPATOSPLENOMEGALY 3 0.0012
176 BRONCHOPNEUMONIA 4 0.0012
177 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
178 ORAL CANDIDIASIS 15 0.0011
179 BRONCHIOLITIS 4 0.0011
180 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 54 0.0011
181 SINUSITIS 115 0.0011
182 STEATORRHOEA 3 0.0011
183 FOOD POISONING 6 0.0011
184 SHOULDER ARTHROPLASTY 3 0.0011
185 INSURANCE ISSUE 17 0.0011
186 FACIAL BONES FRACTURE 4 0.0011
187 THROMBOCYTOSIS 4 0.0011
188 EMPHYSEMA 11 0.0011
189 IRON DEFICIENCY ANAEMIA 10 0.0011
190 APHONIA 15 0.0011
191 ENDOTRACHEAL INTUBATION 3 0.0011
192 POLYP 7 0.0011
193 ILLNESS 109 0.0011
194 BRONCHOSPASM 15 0.0011
195 WHEEZING 62 0.0010
196 END STAGE RENAL DISEASE 19 0.0010
197 HYPERTONIC BLADDER 3 0.0010
198 REHABILITATION THERAPY 4 0.0010
199 ORGANISING PNEUMONIA 5 0.0010
200 GASTROINTESTINAL INFECTION 9 0.0010
201 ATYPICAL PNEUMONIA 3 0.0010
202 PNEUMONIA 324 0.0010
203 METABOLIC ENCEPHALOPATHY 3 0.0010
204 REBOUND ACID HYPERSECRETION 3 0.0010
205 VIRAL INFECTION 33 0.0010
206 FUNGAL SKIN INFECTION 4 0.0010
207 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
208 DYSPNOEA EXERTIONAL 37 0.0010
209 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
210 HAEMOPTYSIS 27 0.0010
211 DERMATITIS CONTACT 11 0.0010
212 INFUSION SITE EXTRAVASATION 6 0.0010
213 BRAIN FOG 15 0.0010
214 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
215 PNEUMOTHORAX 15 0.0009
216 COUGH 265 0.0009
217 TONGUE DISCOMFORT 4 0.0009
218 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 16 0.0009
219 DYSPHONIA 55 0.0009
220 CUSHINGOID 3 0.0009
221 DEVICE OPERATIONAL ISSUE 4 0.0009
222 DECREASED ACTIVITY 10 0.0009
223 MUSCLE STRAIN 8 0.0009
224 HORDEOLUM 4 0.0009
225 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
226 PHARYNGEAL SWELLING 9 0.0009
227 ASPIRATION 10 0.0009
228 FOOD ALLERGY 7 0.0009
229 APPETITE DISORDER 6 0.0009
230 CONCUSSION 7 0.0009
231 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
232 PRODUCT LEAKAGE 5 0.0009
233 EYE INFECTION 10 0.0009
234 NASAL DISCOMFORT 7 0.0009
235 HAEMOGLOBIN INCREASED 4 0.0009
236 DISEASE COMPLICATION 4 0.0009
237 EAR DISORDER 4 0.0009
238 PULMONARY MASS 13 0.0009
239 RESPIRATORY DISTRESS 24 0.0009
240 HYPOPNOEA 3 0.0009
241 HYPOXIA 30 0.0009
242 DECREASED INTEREST 5 0.0008
243 COVID-19 PNEUMONIA 10 0.0008
244 BACTERAEMIA 10 0.0008
245 CHRONIC KIDNEY DISEASE 64 0.0008
246 WRIST FRACTURE 10 0.0008
247 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
248 SPONDYLITIS 3 0.0008
249 ORAL HERPES 16 0.0008
250 DYSPNOEA 461 0.0008
251 ARTHROPOD BITE 6 0.0008
252 HYPERVOLAEMIA 4 0.0008
253 SINUS DISORDER 16 0.0008
254 SCOLIOSIS 5 0.0008
255 IMPAIRED GASTRIC EMPTYING 11 0.0008
256 BLOOD PRESSURE ABNORMAL 16 0.0008
257 LUNG DISORDER 39 0.0008
258 SNORING 3 0.0008
259 FOOT FRACTURE 15 0.0008
260 VENTRICULAR TACHYCARDIA 13 0.0008
261 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
262 ABDOMINAL INFECTION 2 0.0008
263 THROAT IRRITATION 35 0.0008
264 EAR DISCOMFORT 8 0.0008
265 OESOPHAGEAL DISORDER 3 0.0008
266 OROPHARYNGEAL DISCOMFORT 7 0.0008
267 CARDIAC FLUTTER 5 0.0008
268 POOR VENOUS ACCESS 8 0.0008
269 PULMONARY HAEMORRHAGE 6 0.0008
270 SNEEZING 17 0.0008
271 MUSCULOSKELETAL DISCOMFORT 13 0.0008
272 CHEST DISCOMFORT 77 0.0008
273 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
274 COMPRESSION FRACTURE 4 0.0007
275 GINGIVITIS 4 0.0007
276 HEART RATE INCREASED 73 0.0007
277 TACHYPNOEA 10 0.0007
278 PERIPHERAL VENOUS DISEASE 3 0.0007
279 SMALL INTESTINAL OBSTRUCTION 9 0.0007
280 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
281 DEVICE DELIVERY SYSTEM ISSUE 20 0.0007
282 RIB FRACTURE 15 0.0007
283 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
284 SPINAL COMPRESSION FRACTURE 6 0.0007
285 RESPIRATION ABNORMAL 5 0.0007
286 SOCIAL PROBLEM 3 0.0007
287 EAR PAIN 14 0.0007
288 LEUKOCYTOSIS 13 0.0007
289 HEART RATE ABNORMAL 4 0.0007
290 OROPHARYNGEAL PAIN 66 0.0007
291 SLEEP TERROR 3 0.0007
292 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
293 LIGAMENT SPRAIN 7 0.0007
294 COGNITIVE DISORDER 33 0.0007
295 INTENTIONAL DOSE OMISSION 20 0.0007
296 NASAL CONGESTION 41 0.0007
297 BACTERIAL INFECTION 13 0.0007
298 EXERCISE TOLERANCE DECREASED 4 0.0007
299 TOOTH INJURY 3 0.0007
300 URINE OUTPUT DECREASED 6 0.0007
301 DYSPHEMIA 3 0.0007
302 SPINAL OSTEOARTHRITIS 6 0.0007
303 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
304 COVID-19 119 0.0007
305 WHEELCHAIR USER 3 0.0007
306 HYPERLIPIDAEMIA 8 0.0007
307 WEIGHT FLUCTUATION 7 0.0007
308 SYMPTOM RECURRENCE 4 0.0007
309 MENINGITIS ASEPTIC 3 0.0007
310 ANAL INCONTINENCE 6 0.0007
311 THROAT TIGHTNESS 18 0.0007
312 VASCULAR DEVICE INFECTION 3 0.0007
313 INJECTION SITE VESICLES 4 0.0007
314 OSTEOPENIA 10 0.0007
315 HEREDITARY ANGIOEDEMA 7 0.0007
316 ORAL DISCOMFORT 9 0.0006
317 PHARYNGITIS STREPTOCOCCAL 7 0.0006
318 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
319 RESPIRATORY FAILURE 47 0.0006
320 HOSPITALISATION 99 0.0006
321 ROSACEA 3 0.0006
322 SKIN LACERATION 7 0.0006
323 HEPATIC ENCEPHALOPATHY 6 0.0006
324 PELVIC FRACTURE 5 0.0006
325 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
326 PRE-EXISTING CONDITION IMPROVED 4 0.0006
327 RENAL INJURY 19 0.0006
328 GASTROINTESTINAL INFLAMMATION 5 0.0006
329 ARTERIOSCLEROSIS 6 0.0006
330 RESPIRATORY DISORDER 19 0.0006
331 SARCOIDOSIS 3 0.0006
332 ATRIAL FLUTTER 5 0.0006
333 PULMONARY HYPERTENSION 13 0.0006
334 SEIZURE 72 0.0006
335 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
336 INFECTION 89 0.0006
337 ASPHYXIA 5 0.0006
338 INFLUENZA 68 0.0006
339 MUCOUS STOOLS 3 0.0006
340 DRY EYE 30 0.0006
341 VEIN DISORDER 3 0.0006
342 HYPOAESTHESIA ORAL 9 0.0006
343 GASTROOESOPHAGEAL REFLUX DISEASE 48 0.0006
344 EYE PRURITUS 20 0.0006
345 BALANCE DISORDER 51 0.0006
346 FACIAL PARALYSIS 5 0.0006
347 INITIAL INSOMNIA 6 0.0006
348 CARDIAC OPERATION 5 0.0006
349 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
350 LYMPHOEDEMA 4 0.0006
351 FEELING JITTERY 11 0.0006
352 ADRENAL INSUFFICIENCY 7 0.0006
353 TENDERNESS 6 0.0006
354 MALABSORPTION 3 0.0006
355 PRODUCT ODOUR ABNORMAL 6 0.0006
356 TRANSFUSION 6 0.0006
357 RIGHT VENTRICULAR FAILURE 4 0.0006
358 FUNGAL INFECTION 19 0.0006
359 BLOOD LACTIC ACID INCREASED 3 0.0006
360 SPINAL OPERATION 7 0.0006
361 GENERALISED OEDEMA 7 0.0006
362 OBESITY 9 0.0006
363 DIVERTICULUM 4 0.0006
364 BODY HEIGHT DECREASED 6 0.0006
365 PARAESTHESIA ORAL 8 0.0006
366 BEHAVIOUR DISORDER 3 0.0006
367 GASTROENTERITIS VIRAL 10 0.0006
368 UPPER LIMB FRACTURE 11 0.0006
369 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
370 PULMONARY THROMBOSIS 6 0.0005
371 FLUID OVERLOAD 8 0.0005
372 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 39 0.0005
373 EXOSTOSIS 5 0.0005
374 ASTHENOPIA 3 0.0005
375 ANAPHYLACTIC REACTION 30 0.0005
376 SENSITIVE SKIN 4 0.0005
377 STREPTOCOCCAL INFECTION 3 0.0005
378 IMMUNODEFICIENCY 8 0.0005
379 EPISTAXIS 40 0.0005
380 THERAPY INTERRUPTED 38 0.0005
381 PULMONARY CONGESTION 7 0.0005
382 FLUID RETENTION 27 0.0005
383 TENDON PAIN 4 0.0005
384 ATRIAL FIBRILLATION 51 0.0005
385 BOWEL MOVEMENT IRREGULARITY 4 0.0005
386 LOWER LIMB FRACTURE 10 0.0005
387 PRODUCT TASTE ABNORMAL 7 0.0005
388 PRODUCT DOSE OMISSION ISSUE 152 0.0005
389 MUSCULOSKELETAL CHEST PAIN 8 0.0005
390 RETCHING 11 0.0005
391 DIZZINESS POSTURAL 5 0.0005
392 LIMB INJURY 14 0.0005
393 MOBILITY DECREASED 37 0.0005
394 HYPOVOLAEMIA 3 0.0005
395 CHOKING 10 0.0005
396 KIDNEY INFECTION 10 0.0005
397 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
398 BLOOD IRON DECREASED 6 0.0005
399 BLADDER DISORDER 5 0.0005
400 INABILITY TO AFFORD MEDICATION 5 0.0005
401 MACULAR DEGENERATION 6 0.0005
402 MUSCULAR WEAKNESS 57 0.0005
403 SALIVARY HYPERSECRETION 5 0.0005
404 SPINAL FRACTURE 10 0.0005
405 BRAIN INJURY 5 0.0005
406 POOR QUALITY DEVICE USED 5 0.0005
407 TYPE 1 DIABETES MELLITUS 3 0.0005
408 RENAL FAILURE 66 0.0005
409 CONSTIPATION 108 0.0005
410 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
411 DERMATITIS ACNEIFORM 3 0.0005
412 PLEURAL EFFUSION 30 0.0005
413 TENSION 3 0.0005
414 URINARY TRACT INFECTION 84 0.0005
415 EYELID PTOSIS 5 0.0005
416 THERAPY NON-RESPONDER 22 0.0005
417 ABNORMAL FAECES 4 0.0005
418 LARYNGEAL OEDEMA 3 0.0005
419 OSTEOPOROSIS 20 0.0005
420 PIGMENTATION DISORDER 3 0.0005
421 TEMPERATURE INTOLERANCE 5 0.0005
422 TACHYCARDIA 43 0.0005
423 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
424 EYE DISCHARGE 5 0.0005
425 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
426 GASTROENTERITIS 7 0.0005
427 PETECHIAE 5 0.0005
428 BLOOD SODIUM DECREASED 9 0.0005
429 KNEE ARTHROPLASTY 10 0.0005
430 HEAD INJURY 15 0.0005
431 HYPOTENSION 95 0.0005
432 INCONTINENCE 5 0.0005
433 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
434 HYPOTHYROIDISM 15 0.0005
435 EATING DISORDER 10 0.0005
436 PULMONARY FIBROSIS 9 0.0005
437 DIVERTICULITIS 13 0.0005
438 JOINT INJURY 10 0.0005
439 SCAR 8 0.0005
440 HAEMOGLOBIN ABNORMAL 3 0.0005
441 SKIN HYPERPIGMENTATION 4 0.0005
442 BLOOD MAGNESIUM DECREASED 4 0.0005
443 HIATUS HERNIA 6 0.0005
444 HERPES SIMPLEX 3 0.0005
445 MIGRAINE 44 0.0005
446 SKIN SWELLING 4 0.0005
447 CARDIAC FAILURE CONGESTIVE 37 0.0005
448 NEPHROLITHIASIS 21 0.0005
449 STAPHYLOCOCCAL INFECTION 15 0.0005
450 LUNG INFILTRATION 4 0.0005
451 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
452 PALPITATIONS 53 0.0005
453 ABDOMINAL ABSCESS 2 0.0005
454 LUNG INFECTION 7 0.0005
455 CARDIAC FAILURE ACUTE 3 0.0004
456 FACIAL PAIN 4 0.0004
457 POST-TRAUMATIC STRESS DISORDER 3 0.0004
458 QUALITY OF LIFE DECREASED 6 0.0004
459 MALNUTRITION 5 0.0004
460 BREAST MASS 3 0.0004
461 SKIN INFECTION 5 0.0004
462 ACUTE KIDNEY INJURY 68 0.0004
463 STATUS EPILEPTICUS 5 0.0004
464 PNEUMONIA ASPIRATION 11 0.0004
465 SLEEP DISORDER 31 0.0004
466 EYE MOVEMENT DISORDER 3 0.0004
467 JOINT EFFUSION 3 0.0004
468 NERVE COMPRESSION 4 0.0004
469 PERICARDIAL EFFUSION 10 0.0004
470 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
471 CHEST PAIN 80 0.0004
472 PRODUCT DISTRIBUTION ISSUE 4 0.0004
473 CONJUNCTIVITIS 8 0.0004
474 BLOOD POTASSIUM INCREASED 7 0.0004
475 SEPSIS 48 0.0004
476 ELECTROLYTE IMBALANCE 5 0.0004
477 NASOPHARYNGITIS 79 0.0004
478 NEPHROPATHY 4 0.0004
479 MULTIPLE FRACTURES 7 0.0004
480 PAPULE 3 0.0004
481 SQUAMOUS CELL CARCINOMA 4 0.0004
482 GASTROINTESTINAL DISORDER 38 0.0004
483 SINUS TACHYCARDIA 6 0.0004
484 PRODUCT PACKAGING ISSUE 4 0.0004
485 PRODUCT SUPPLY ISSUE 3 0.0004
486 CATARACT 25 0.0004
487 DRY MOUTH 34 0.0004
488 CONTUSION 40 0.0004
489 FALL 138 0.0004
490 LOCALISED INFECTION 10 0.0004
491 HYPOKALAEMIA 19 0.0004
492 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
493 TREMOR 68 0.0004
494 HEPATOMEGALY 4 0.0004
495 BLINDNESS TRANSIENT 3 0.0004
496 HYPOPHOSPHATAEMIA 3 0.0004
497 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
498 HOSPICE CARE 4 0.0004
499 HYPERCALCAEMIA 5 0.0004
500 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
501 PHARYNGITIS 5 0.0004
502 ABDOMINAL TENDERNESS 2 0.0004
503 EYE IRRITATION 23 0.0004
504 PROCEDURAL PAIN 11 0.0004
505 TASTE DISORDER 8 0.0004
506 TROPONIN INCREASED 3 0.0004
507 DEMENTIA 11 0.0004
508 DRY THROAT 4 0.0004
509 ABDOMINAL DISTENSION 41 0.0004
510 SLUGGISHNESS 4 0.0004
511 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
512 LIPASE INCREASED 3 0.0004
513 RENAL FAILURE CHRONIC 3 0.0004
514 ATRIOVENTRICULAR BLOCK 3 0.0004
515 PRODUCT USE IN UNAPPROVED INDICATION 96 0.0004
516 EXPOSURE VIA SKIN CONTACT 10 0.0004
517 RESTLESS LEGS SYNDROME 7 0.0004
518 NODULE 5 0.0004
519 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
520 CYANOSIS 6 0.0004
521 PRODUCT USE COMPLAINT 6 0.0004
522 ANHEDONIA 10 0.0004
523 TOOTH INFECTION 5 0.0004
524 RENAL CYST 3 0.0004
525 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 68 0.0004
526 CYSTITIS 12 0.0004
527 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
528 MALIGNANT MELANOMA 5 0.0004
529 SENSORY LOSS 3 0.0004
530 RHINITIS 3 0.0004
531 MYASTHENIA GRAVIS 3 0.0004
532 RHINORRHOEA 24 0.0004
533 POST PROCEDURAL INFECTION 3 0.0004
534 DECUBITUS ULCER 3 0.0004
535 PNEUMONITIS 10 0.0004
536 SLEEP APNOEA SYNDROME 7 0.0004
537 ESCHERICHIA INFECTION 3 0.0004
538 LACRIMATION INCREASED 11 0.0004
539 MELAENA 8 0.0004
540 ACUTE CORONARY SYNDROME 3 0.0004
541 DENTAL CARIES 4 0.0004
542 FOOT DEFORMITY 4 0.0004
543 THROMBOSIS 29 0.0004
544 NERVE INJURY 4 0.0004
545 DRY SKIN 48 0.0004
546 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
547 GAIT INABILITY 12 0.0004
548 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
549 SURGERY 21 0.0004
550 ORAL PAIN 8 0.0004
551 FACE OEDEMA 6 0.0004
552 BLINDNESS UNILATERAL 5 0.0004
553 BLOOD PRESSURE INCREASED 54 0.0004
554 CARDIAC DISORDER 33 0.0004
555 SWOLLEN TONGUE 11 0.0004
556 VITAMIN D DECREASED 3 0.0004
557 HAEMATURIA 12 0.0004
558 INTERNAL HAEMORRHAGE 4 0.0003
559 SKIN DISCOLOURATION 16 0.0003
560 HERPES ZOSTER 20 0.0003
561 DRUG INTERACTION 55 0.0003
562 HYSTERECTOMY 3 0.0003
563 DEHYDRATION 46 0.0003
564 OEDEMA PERIPHERAL 42 0.0003
565 BACK PAIN 80 0.0003
566 METABOLIC ACIDOSIS 11 0.0003
567 DEVICE USE ISSUE 6 0.0003
568 HEART RATE DECREASED 12 0.0003
569 CHILLS 40 0.0003
570 NECK PAIN 19 0.0003
571 ABDOMINAL DISCOMFORT 57 0.0003
572 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
573 RESPIRATORY RATE INCREASED 3 0.0003
574 CELLULITIS 17 0.0003
575 EYE PAIN 19 0.0003
576 CARDIAC FAILURE 27 0.0003
577 THIRST 6 0.0003
578 FLATULENCE 19 0.0003
579 CARDIO-RESPIRATORY ARREST 14 0.0003
580 EYE DISORDER 11 0.0003
581 GOUT 6 0.0003
582 INFUSION RELATED REACTION 22 0.0003
583 SWELLING 31 0.0003
584 UNEVALUABLE EVENT 25 0.0003
585 LIP SWELLING 11 0.0003
586 LIP DRY 3 0.0003
587 PELVIC PAIN 6 0.0003
588 WEIGHT DECREASED 92 0.0003
589 HYPERSENSITIVITY 61 0.0003
590 FATIGUE 255 0.0003
591 IRRITABLE BOWEL SYNDROME 7 0.0003
592 RESPIRATORY DEPRESSION 4 0.0003
593 DEVICE RELATED INFECTION 5 0.0003
594 FEELING COLD 9 0.0003
595 CYST 4 0.0003
596 ILEUS 4 0.0003
597 PRODUCT PRESCRIBING ISSUE 7 0.0003
598 DIARRHOEA HAEMORRHAGIC 3 0.0003
599 VISION BLURRED 44 0.0003
600 INTESTINAL OBSTRUCTION 12 0.0003
601 COLITIS 12 0.0003
602 DYSPEPSIA 31 0.0003
603 EYE INFLAMMATION 3 0.0003
604 HYPERKALAEMIA 11 0.0003
605 SCIATICA 5 0.0003
606 ABSCESS 5 0.0003
607 INTRAOCULAR PRESSURE INCREASED 4 0.0003
608 PYREXIA 108 0.0003
609 DEPRESSION 71 0.0003
610 HYPERTENSION 66 0.0003
611 ROTATOR CUFF SYNDROME 4 0.0003
612 PANCREATITIS ACUTE 7 0.0003
613 HEADACHE 195 0.0003
614 HYPERCHOLESTEROLAEMIA 3 0.0003
615 CHROMATURIA 7 0.0003
616 NEEDLE ISSUE 9 0.0003
617 DYSSTASIA 9 0.0003
618 INSOMNIA 82 0.0003
619 AUTOIMMUNE DISORDER 3 0.0003
620 RENAL TUBULAR NECROSIS 3 0.0003
621 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
622 VITREOUS FLOATERS 3 0.0003
623 SHOCK 7 0.0003
624 BEDRIDDEN 4 0.0003
625 MUSCLE TWITCHING 7 0.0003
626 DERMATITIS ATOPIC 16 0.0003
627 SARS-COV-2 TEST POSITIVE 4 0.0003
628 PANIC ATTACK 11 0.0003
629 BLOOD POTASSIUM DECREASED 9 0.0003
630 CORONARY ARTERY DISEASE 9 0.0003
631 DECREASED APPETITE 69 0.0003
632 DYSGEUSIA 22 0.0003
633 EYE SWELLING 11 0.0003
634 PRODUCT SUBSTITUTION ISSUE 17 0.0003
635 OEDEMA 16 0.0003
636 PRURITUS 113 0.0003
637 FEELING HOT 18 0.0003
638 MOOD ALTERED 8 0.0003
639 NEUTROPHIL COUNT INCREASED 3 0.0003
640 PRODUCT USE ISSUE 55 0.0003
641 CORONARY ARTERY OCCLUSION 4 0.0003
642 BLOOD PRESSURE FLUCTUATION 7 0.0003
643 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
644 HYPOGLYCAEMIA 14 0.0003
645 CARPAL TUNNEL SYNDROME 4 0.0003
646 NEUROTOXICITY 5 0.0003
647 EOSINOPHILIA 5 0.0003
648 BLISTER 16 0.0003
649 PAIN 175 0.0003
650 JOINT DISLOCATION 3 0.0003
651 FEELING ABNORMAL 68 0.0003
652 PAIN IN JAW 8 0.0003
653 DRUG ERUPTION 5 0.0003
654 AGEUSIA 7 0.0003
655 HIP FRACTURE 9 0.0003
656 RED BLOOD CELL COUNT DECREASED 8 0.0003
657 CONDITION AGGRAVATED 85 0.0003
658 PARALYSIS 4 0.0003
659 ASTHENIA 105 0.0003
660 ANGINA PECTORIS 8 0.0003
661 HYPERSOMNIA 8 0.0003
662 RENAL DISORDER 13 0.0003
663 SKIN CANCER 6 0.0003
664 DISCOMFORT 17 0.0003
665 ABDOMINAL PAIN UPPER 57 0.0003
666 ABDOMINAL PAIN LOWER 7 0.0003
667 RASH PRURITIC 15 0.0003
668 FAECES DISCOLOURED 6 0.0003
669 DIZZINESS 138 0.0003
670 SWELLING FACE 18 0.0003
671 BACK INJURY 3 0.0003
672 SEPTIC SHOCK 12 0.0003
673 PRODUCT DISPENSING ERROR 6 0.0003
674 URTICARIA 46 0.0003
675 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
676 CHOLELITHIASIS 9 0.0003
677 HYPERGLYCAEMIA 10 0.0003
678 VISUAL IMPAIRMENT 34 0.0003
679 ANXIETY 78 0.0003
680 OCULAR HYPERAEMIA 13 0.0003
681 ERYTHEMA 56 0.0003
682 ASCITES 8 0.0003
683 TOOTH FRACTURE 3 0.0003
684 RASH ERYTHEMATOUS 13 0.0003
685 ARTHRALGIA 113 0.0003
686 EXPIRED PRODUCT ADMINISTERED 9 0.0003
687 BLOOD GLUCOSE ABNORMAL 5 0.0003
688 CARDIOMYOPATHY 4 0.0003
689 SKIN DISORDER 9 0.0003
690 HYPERTENSIVE CRISIS 3 0.0003
691 DIARRHOEA 174 0.0003
692 GLOSSODYNIA 6 0.0003
693 PULMONARY OEDEMA 12 0.0003
694 MIDDLE INSOMNIA 5 0.0003
695 DEAFNESS 7 0.0003
696 ARTHRITIS 21 0.0003
697 MALAISE 117 0.0003
698 HEPATIC CIRRHOSIS 5 0.0003
699 HEART RATE IRREGULAR 6 0.0003
700 ECONOMIC PROBLEM 4 0.0003
701 OFF LABEL USE 231 0.0003
702 POLLAKIURIA 11 0.0003
703 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
704 DYSPHAGIA 25 0.0003
705 HAEMOGLOBIN DECREASED 27 0.0003
706 NEUROPATHY PERIPHERAL 25 0.0003
707 MEMORY IMPAIRMENT 36 0.0003
708 INJECTION SITE RASH 8 0.0003
709 LETHARGY 15 0.0003
710 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
711 POST PROCEDURAL COMPLICATION 5 0.0003
712 SYNCOPE 26 0.0003
713 PERIPHERAL SWELLING 40 0.0003
714 OSTEOARTHRITIS 11 0.0003
715 RENAL FAILURE ACUTE 11 0.0003
716 WEIGHT INCREASED 58 0.0003
717 ANKLE FRACTURE 4 0.0003
718 VOMITING 121 0.0003
719 DEVICE MALFUNCTION 18 0.0003
720 SPINAL PAIN 3 0.0003
721 LYMPHADENOPATHY 9 0.0003
722 ARRHYTHMIA 12 0.0003
723 MENTAL DISORDER 11 0.0003
724 DISEASE RECURRENCE 12 0.0003
725 MYOCLONUS 3 0.0003
726 ACCIDENT 3 0.0003
727 WOUND 7 0.0003
728 NAUSEA 198 0.0002
729 ECZEMA 13 0.0002
730 PRODUCT PHYSICAL ISSUE 5 0.0002
731 NOCTURIA 3 0.0002
732 MUSCLE TIGHTNESS 4 0.0002
733 PRESYNCOPE 6 0.0002
734 BACK DISORDER 4 0.0002
735 BRADYCARDIA 13 0.0002
736 PRODUCT DOSE OMISSION 16 0.0002
737 BODY TEMPERATURE INCREASED 5 0.0002
738 ADVERSE DRUG REACTION 22 0.0002
739 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
740 CARDIOMEGALY 3 0.0002
741 INJECTION SITE MASS 9 0.0002
742 LUNG NEOPLASM MALIGNANT 10 0.0002
743 ABDOMINAL PAIN 56 0.0002
744 ROAD TRAFFIC ACCIDENT 10 0.0002
745 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
746 BRAIN OEDEMA 3 0.0002
747 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
748 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
749 ANAEMIA 45 0.0002
750 MYALGIA 40 0.0002
751 GAIT DISTURBANCE 45 0.0002
752 RASH 102 0.0002
753 ARTHROPATHY 13 0.0002
754 LIVER FUNCTION TEST INCREASED 5 0.0002
755 UNRESPONSIVE TO STIMULI 6 0.0002
756 HAEMATOMA 6 0.0002
757 TOXICITY TO VARIOUS AGENTS 39 0.0002
758 DIPLOPIA 6 0.0002
759 HAEMORRHAGE 24 0.0002
760 MUSCLE SPASMS 42 0.0002
761 RASH MACULAR 8 0.0002
762 JOINT STIFFNESS 6 0.0002
763 FEMUR FRACTURE 7 0.0002
764 HEAD DISCOMFORT 4 0.0002
765 GALLBLADDER DISORDER 4 0.0002
766 SKIN BURNING SENSATION 16 0.0002
767 RASH PAPULAR 5 0.0002
768 FREQUENT BOWEL MOVEMENTS 6 0.0002
769 PSORIATIC ARTHROPATHY 9 0.0002
770 PULMONARY EMBOLISM 21 0.0002
771 OSTEOMYELITIS 4 0.0002
772 PALLOR 6 0.0002
773 HEPATIC ENZYME INCREASED 15 0.0002
774 TREATMENT NONCOMPLIANCE 12 0.0002
775 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
776 RESPIRATORY ARREST 6 0.0002
777 TINNITUS 10 0.0002
778 DEEP VEIN THROMBOSIS 14 0.0002
779 HUNGER 3 0.0002
780 THROMBOCYTOPENIA 24 0.0002
781 BLOOD CREATININE INCREASED 14 0.0002
782 THERAPY CESSATION 11 0.0002
783 BURNING SENSATION 15 0.0002
784 BLOOD TEST ABNORMAL 3 0.0002
785 INFLAMMATION 11 0.0002
786 SKIN REACTION 3 0.0002
787 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
788 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
789 FEBRILE NEUTROPENIA 14 0.0002
790 BLOOD PRESSURE DECREASED 14 0.0002
791 NERVOUSNESS 11 0.0002
792 MUSCULOSKELETAL DISORDER 4 0.0002
793 DEATH 181 0.0002
794 CARDIOGENIC SHOCK 3 0.0002
795 ACCIDENTAL UNDERDOSE 3 0.0002
796 PANCREATIC CARCINOMA 6 0.0002
797 GLAUCOMA 4 0.0002
798 ERUCTATION 4 0.0002
799 PLASMA CELL MYELOMA 8 0.0002
800 SKIN FISSURES 4 0.0002
801 DRUG DOSE OMISSION BY DEVICE 16 0.0002
802 DISTURBANCE IN ATTENTION 11 0.0002
803 INJECTION SITE REACTION 14 0.0002
804 LIVER DISORDER 9 0.0002
805 DELIRIUM 7 0.0002
806 DRUG INEFFECTIVE 265 0.0002
807 HAEMORRHAGE INTRACRANIAL 3 0.0002
808 SOMNOLENCE 40 0.0002
809 ACNE 15 0.0002
810 PRODUCT COMPLAINT 5 0.0002
811 FEEDING DISORDER 4 0.0002
812 DEVICE FAILURE 3 0.0002
813 VERTIGO 12 0.0002
814 PAIN IN EXTREMITY 58 0.0002
815 HIP ARTHROPLASTY 3 0.0002
816 INJECTION SITE SWELLING 15 0.0002
817 HYPOPHAGIA 5 0.0002
818 PHARYNGEAL OEDEMA 3 0.0002
819 INJECTION SITE WARMTH 4 0.0002
820 PRODUCT STORAGE ERROR 17 0.0002
821 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
822 TENDONITIS 3 0.0002
823 EJECTION FRACTION DECREASED 3 0.0002
824 INJECTION SITE PAIN 59 0.0002
825 PRODUCT QUALITY ISSUE 26 0.0002
826 RESTLESSNESS 7 0.0002
827 MUCOSAL INFLAMMATION 5 0.0002
828 DERMATITIS 4 0.0002
829 SPEECH DISORDER 10 0.0002
830 RECTAL HAEMORRHAGE 8 0.0002
831 IRRITABILITY 11 0.0002
832 THERAPEUTIC RESPONSE DECREASED 11 0.0002
833 DRUG LEVEL INCREASED 3 0.0002
834 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
835 HYPOAESTHESIA 27 0.0002
836 COAGULOPATHY 3 0.0002
837 NEOPLASM MALIGNANT 12 0.0002
838 CONFUSIONAL STATE 29 0.0002
839 BLOOD UREA INCREASED 3 0.0002
840 DEVICE ISSUE 16 0.0002
841 PARAESTHESIA 28 0.0002
842 HYPONATRAEMIA 10 0.0002
843 AGITATION 13 0.0002
844 PRODUCT AVAILABILITY ISSUE 4 0.0002
845 INJECTION SITE BRUISING 14 0.0002
846 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
847 PARANOIA 3 0.0002
848 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
849 MULTI-ORGAN FAILURE 3 0.0002
850 SYRINGE ISSUE 3 0.0002
851 PANCREATITIS 9 0.0002
852 LYMPHOCYTE COUNT DECREASED 3 0.0002
853 LABORATORY TEST ABNORMAL 5 0.0002
854 DRUG ABUSE 14 0.0002
855 PRODUCT PRESCRIBING ERROR 4 0.0002
856 RENAL IMPAIRMENT 14 0.0002
857 BLOOD GLUCOSE DECREASED 8 0.0002
858 MENTAL IMPAIRMENT 4 0.0002
859 STOMATITIS 10 0.0002
860 BONE DISORDER 3 0.0002
861 FIBROMYALGIA 4 0.0002
862 UNDERDOSE 12 0.0002
863 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
864 EPILEPSY 5 0.0002
865 INJECTION SITE URTICARIA 4 0.0002
866 DYSURIA 6 0.0002
867 ENCEPHALOPATHY 4 0.0002
868 INCORRECT DOSE ADMINISTERED 37 0.0002
869 LIMB DISCOMFORT 5 0.0002
870 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
871 THINKING ABNORMAL 3 0.0002
872 DISEASE PROGRESSION 19 0.0002
873 BONE DENSITY DECREASED 5 0.0002
874 PHOTOPHOBIA 3 0.0002
875 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
876 BLOOD URINE PRESENT 3 0.0002
877 ALOPECIA 31 0.0002
878 PROTEINURIA 3 0.0002
879 JOINT SWELLING 19 0.0002
880 COLITIS ULCERATIVE 7 0.0002
881 DRUG RESISTANCE 4 0.0002
882 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
883 LACTIC ACIDOSIS 5 0.0002
884 HAEMORRHOIDS 3 0.0002
885 BONE PAIN 9 0.0002
886 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
887 OVERDOSE 33 0.0002
888 SUICIDAL IDEATION 14 0.0002
889 IMPAIRED HEALING 5 0.0002
890 ABNORMAL BEHAVIOUR 6 0.0002
891 BLOOD CHOLESTEROL INCREASED 7 0.0002
892 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
893 URINARY RETENTION 5 0.0001
894 INJECTION SITE PRURITUS 10 0.0001
895 FULL BLOOD COUNT DECREASED 3 0.0001
896 BLOOD GLUCOSE INCREASED 28 0.0001
897 INTENTIONAL PRODUCT MISUSE 13 0.0001
898 PRODUCT ADMINISTRATION ERROR 3 0.0001
899 LOSS OF CONSCIOUSNESS 19 0.0001
900 CEREBROVASCULAR ACCIDENT 25 0.0001
901 HYPERHIDROSIS 19 0.0001
902 BLINDNESS 6 0.0001
903 SKIN LESION 4 0.0001
904 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
905 HAEMATOCHEZIA 8 0.0001
906 MENTAL STATUS CHANGES 4 0.0001
907 DEVICE USE ERROR 5 0.0001
908 HALLUCINATION, VISUAL 3 0.0001
909 ADVERSE EVENT 13 0.0001
910 PLATELET COUNT DECREASED 15 0.0001
911 POOR QUALITY SLEEP 3 0.0001
912 NO ADVERSE EVENT 25 0.0001
913 FLUSHING 14 0.0001
914 ACUTE MYOCARDIAL INFARCTION 4 0.0001
915 URINARY INCONTINENCE 4 0.0001
916 DRUG INTOLERANCE 13 0.0001
917 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
918 DRUG DOSE OMISSION 22 0.0001
919 DYSARTHRIA 5 0.0001
920 HALLUCINATION 10 0.0001
921 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
922 DIABETES MELLITUS 10 0.0001
923 SKIN IRRITATION 6 0.0001
924 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
925 COMA 6 0.0001
926 MOOD SWINGS 4 0.0001
927 MOVEMENT DISORDER 4 0.0001
928 NIGHT SWEATS 4 0.0001
929 INTERSTITIAL LUNG DISEASE 6 0.0001
930 DEVICE BREAKAGE 5 0.0001
931 LIVER INJURY 3 0.0001
932 INFLUENZA LIKE ILLNESS 10 0.0001
933 HOT FLUSH 9 0.0001
934 ANGER 4 0.0001
935 NIGHTMARE 4 0.0001
936 DEVICE LEAKAGE 5 0.0001
937 ILL-DEFINED DISORDER 7 0.0001
938 MUSCULOSKELETAL STIFFNESS 10 0.0001
939 GASTRITIS 3 0.0001
940 INJECTION SITE ERYTHEMA 14 0.0001
941 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
942 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
943 BREAST CANCER FEMALE 3 0.0001
944 FEAR 3 0.0001
945 BLOOD BILIRUBIN INCREASED 3 0.0001
946 CRYING 4 0.0001
947 C-REACTIVE PROTEIN INCREASED 4 0.0001
948 ACCIDENTAL OVERDOSE 4 0.0001
949 CARDIAC ARREST 9 0.0001
950 HEPATIC FUNCTION ABNORMAL 4 0.0001
951 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
952 PSYCHOTIC DISORDER 3 0.0001
953 DISORIENTATION 4 0.0001
954 APHASIA 3 0.0001
955 EMOTIONAL DISTRESS 12 0.0001
956 DYSKINESIA 4 0.0001
957 NEUTROPHIL COUNT DECREASED 4 0.0001
958 DRUG ADMINISTRATION ERROR 3 0.0001
959 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
960 MYOCARDIAL INFARCTION 17 0.0001
961 EMOTIONAL DISORDER 3 0.0001
962 RHEUMATOID ARTHRITIS 11 0.0001
963 NERVOUS SYSTEM DISORDER 3 0.0001
964 DEPRESSED MOOD 5 0.0001
965 HYPOACUSIS 4 0.0001
966 OSTEONECROSIS 3 0.0001
967 VISUAL ACUITY REDUCED 3 0.0001
968 MEDICATION ERROR 5 0.0001
969 NEUTROPENIA 12 0.0001
970 GASTRIC DISORDER 3 0.0001
971 NEOPLASM PROGRESSION 3 0.0001
972 INJURY 6 0.0001
973 PSORIASIS 11 0.0001
974 PRODUCT ADHESION ISSUE 3 0.0001
975 SKIN EXFOLIATION 7 0.0001
976 DRUG EFFECT INCOMPLETE 3 0.0001
977 AGGRESSION 4 0.0001
978 EXTRA DOSE ADMINISTERED 3 0.0001
979 ABNORMAL DREAMS 2 0.0001
980 PANCYTOPENIA 4 0.0001
981 CONVULSION 4 0.0001
982 BLADDER CANCER 4 0.0001
983 INJECTION SITE HAEMORRHAGE 5 0.0001
984 LEUKOPENIA 3 0.0001
985 MUSCULOSKELETAL PAIN 3 0.0001
986 BREAST CANCER 5 0.0001
987 ABORTION SPONTANEOUS 2 0.0000
988 EXPOSURE DURING PREGNANCY 3 0.0000
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
990 TREATMENT FAILURE 3 0.0000
991 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000